Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lannebo Fonder is a leading independent asset management firm based in Stockholm, Sweden, founded in 2000. The company specializes in active management with a focus on Nordic equities, small-cap investments, and fixed-income securities. While Lannebo is a financial institution, it is a significant player in the healthcare sector as an institutional investor. Its specialized funds, such as Lannebo Teknik and Lannebo Vision, maintain substantial portfolios in biotechnology, medical technology, and pharmaceuticals. The firm is known for its fundamental research-driven approach and its commitment to active ownership in its portfolio companies. In 2023, Lannebo was acquired by the private equity firm Nordic Capital to be integrated into a broader Nordic wealth management platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lannebo Fonder.